Beauty Health (SKIN) Competitors

SI-BONE (NASDAQ:SIBN) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Do analysts rate SIBN or SKIN?

SI-BONE currently has a consensus target price of $22.50, indicating a potential upside of 29.16%. Beauty Health has a consensus target price of $1.42, indicating a potential downside of 7.41%. Given SI-BONE's stronger consensus rating and higher possible upside, equities analysts plainly believe SI-BONE is more favorable than Beauty Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SI-BONE	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Beauty Health	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Does the media prefer SIBN or SKIN?

In the previous week, Beauty Health had 9 more articles in the media than SI-BONE. MarketBeat recorded 18 mentions for Beauty Health and 9 mentions for SI-BONE. SI-BONE's average media sentiment score of 1.22 beat Beauty Health's score of 0.39 indicating that SI-BONE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SI-BONE	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beauty Health	6 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has better earnings & valuation, SIBN or SKIN?

SI-BONE has higher earnings, but lower revenue than Beauty Health. SI-BONE is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SI-BONE	$176.60M	4.20	-$43.34M	-$0.64	-27.22
Beauty Health	$322.47M	0.60	-$100.12M	-$0.41	-3.73

Is SIBN or SKIN more profitable?

Beauty Health has a net margin of -8.11% compared to SI-BONE's net margin of -23.82%. SI-BONE's return on equity of -22.51% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SI-BONE	-23.82%	-22.51%	-16.53%
Beauty Health	-8.11%	-44.83%	-3.54%

Which has more risk & volatility, SIBN or SKIN?

SI-BONE has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.

Does the MarketBeat Community favor SIBN or SKIN?

SI-BONE received 135 more outperform votes than Beauty Health when rated by MarketBeat users. Likewise, 69.17% of users gave SI-BONE an outperform vote while only 44.94% of users gave Beauty Health an outperform vote.

Company	Underperform	Outperform
SI-BONE	Outperform Votes 175 69.17%	Underperform Votes 78 30.83%
Beauty Health	Outperform Votes 40 44.94%	Underperform Votes 49 55.06%

Do insiders & institutionals have more ownership in SIBN or SKIN?

98.1% of SI-BONE shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 4.0% of SI-BONE shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

SI-BONE beats Beauty Health on 10 of the 18 factors compared between the two stocks.